Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery
The purpose of this study is to compare the effectiveness of Nepafenac Ophthalmic
Suspension, 0.1% eye drops to Acular LS eye drops, used before and after cataract surgery,
for treating inflammation in the eye.
Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema
Federal University of São Paulo
Diabetics retinopathy remains the major threat to sight in the working age population in the
developed world. Furthermore, it is increasing as a major cause of blindness in other parts
of the world, especially developing countries. Diabetic macular edema (DME) is a
manifestation of diabetic retinopathy that produces loss of central vision.
The triamcinolone intravitreal injection (1-4mg) is indicated to treatment of diabetic
macular edema and it is considered an important treatment since it improves the visual
acuity of patients with resolution of edema.
Nepafenac is a non-steroidal anti-inflammatory drug (NSAID), usually sold as a prescription
eye drop (0.1% solution). Nepafenac is manufactured by Alcon as Nevanac. It is approved by
FDA as well as ANVISA. Pre-clinical studies suggest this medication showed efficacy to treat
ocular posterior segment inflammation.
The purpose of this study is evaluate the efficacy of intravitreal triamcinolone associated
with nepafenac eye drops as treatment of diabetic macular edema.
Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in Facetectomies
Clinica Oftamologica Zona Sul
The main objective of this study is to compare the effect of preoperative use of
anti-inflammatory topical prednisolone acetate 1%, nepafenac 0.1% and ketorolac tromethamine
0.4% of, plus a placebo, in maintaining the intra-operative mydriasis in extraction.
This preview shows a limited data set Subscribe for full access, or try a Trial
Export unavailable in trial. Subscribe for complete access.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.